AHG · Nasdaq · CIK 0001702318
Akso Health Group
Akso Health Group’s most recent SEC filing in our snapshot is a Form 20-F filed on Jul 23, 2026. In fiscal 2026 (year ended Mar 31, 2026) it reported revenue of $13.8M and net income of -$18.7M, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Akso Health Group
- Ticker
- AHG
- SEC Central Index Key (CIK)
- 0001702318
- Industry (SIC)
- Services-Business Services, NEC (code 7389)
- Business address
- QINGDAO PILOT FREE TRADE ZONE, China
- State or country of incorporation
- Cayman Islands
- Fiscal year ends
- March 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #2405 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Akso Health Group’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2022 ended Mar 31, 2022 | FY2023 ended Mar 31, 2023 | FY2024 ended Mar 31, 2024 | FY2025 ended Mar 31, 2025 | FY2026 ended Mar 31, 2026 |
|---|---|---|---|---|---|
| Revenue | $6.0M | $13.2M | $2.4M | $14.8M | $13.8M |
| Net income | -$16.9M | -$1.4M | -$9.5M | -$135.0M | -$18.7M |
| Diluted EPS | -$0.28 | -$0.02 | $0.07 | $0.16 | $0.01 |
| Total assets | $62.8M | $20.5M | $142.0M | $215.0M | $189.6M |
| Cash and equivalents | $18.4M | $7.9M | $85.2M | $176.2M | $170.6K |
XBRL tags used: revenue = Revenues; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
Recent SEC filings
The 40 newest documents filed by or about Akso Health Group, by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Jul 23, 2026 | 20-F | ANNUAL REPORT· period Mar 31, 2026 | Document · Index |
| May 13, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 13, 2026 | Document · Index |
| Apr 6, 2026 | 3 | Initial statement of beneficial ownership· period Apr 6, 2026 | Document · Index |
| Mar 30, 2026 | 3 | Initial statement of beneficial ownership· period Mar 30, 2026 | Document · Index |
| Mar 27, 2026 | 3 | Initial statement of beneficial ownership· period Mar 27, 2026 | Document · Index |
| Mar 23, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Mar 23, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Mar 18, 2026 | 3 | Initial statement of beneficial ownership· period Mar 18, 2026 | Document · Index |
| Feb 10, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Sep 30, 2025 | Document · Index |
| Aug 14, 2025 | 20-F | ANNUAL REPORT· period Mar 31, 2025 | Document · Index |
| Jul 31, 2025 | NT 20-F | NT 20-F· period Mar 31, 2025 | Document · Index |
| Jun 6, 2025 | EFFECT | EFFECT | Document · Index |
| Jun 5, 2025 | CORRESP | CORRESP | Document · Index |
| May 22, 2025 | CORRESP | CORRESP | Document · Index |
| May 22, 2025 | F-3/A | AMENDMENT NO. 3 TO FORM F-3 | Document · Index |
| May 1, 2025 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 1, 2025 | Document · Index |
| Mar 28, 2025 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Sep 30, 2024 | Document · Index |
| Jan 30, 2025 | UPLOAD | UPLOAD | Document · Index |
| Jan 6, 2025 | F-3/A | AMENDMENT NO. 2 TO FORM F-3 | Document · Index |
| Jan 6, 2025 | CORRESP | CORRESP | Document · Index |
| Dec 17, 2024 | UPLOAD | UPLOAD | Document · Index |
| Nov 26, 2024 | F-3/A | AMENDMENT NO. 1 TO FORM F-3 | Document · Index |
| Nov 26, 2024 | RW | WITHDRAWAL REQUEST | Document · Index |
| Nov 21, 2024 | F-3/A | AMENDMENT NO. 1 TO FORM F-3 | Document · Index |
| Nov 8, 2024 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Nov 8, 2024 | Document · Index |
| Sep 30, 2024 | UPLOAD | UPLOAD | Document · Index |
| Jul 30, 2024 | 20-F | ANNUAL REPORT· period Mar 31, 2024 | Document · Index |
| Jun 28, 2024 | CORRESP | CORRESP | Document · Index |
| Jun 24, 2024 | F-6 POS | F-6 POS | Document · Index |
| Jun 14, 2024 | UPLOAD | UPLOAD | Document · Index |
| May 7, 2024 | CORRESP | CORRESP | Document · Index |
| May 2, 2024 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 2, 2024 | Document · Index |
| Mar 26, 2024 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Mar 26, 2024 | Document · Index |
| Mar 20, 2024 | UPLOAD | UPLOAD | Document · Index |
| Mar 19, 2024 | UPLOAD | UPLOAD | Document · Index |
| Mar 8, 2024 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Mar 8, 2024 | Document · Index |
| Mar 7, 2024 | 424B5 | PROSPECTUS SUPPLEMENT | Document · Index |
| Feb 23, 2024 | F-3 | REGISTRATION STATEMENT | Document · Index |
| Jan 29, 2024 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jan 29, 2024 | Document · Index |
Insider filing activity
0 Form 4 filings appear in Akso Health Group’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Services-Business Services, NEC
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001702318 and XBRL company facts. Akso Health Group on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement